Sawitzki Lab

Translational Immunology Group at @ChariteBerlin and @berlinnovation. Posts by lab members.

[Sawitzki Lab @SawitzkiLab]

Very exciting week for Sawitzki Lab! 🎉 We’ve moved into brand-new lab spaces at the Rahel Hirsch Center for Translational Medicine (BIH & Charité).

Plus, we’ve made the leap to Bluesky where you will find us under the same handle! 🚀

[Sawitzki Lab @SawitzkiLab]

A great collaborative effort by Birgit Sawitzki, Lev Petrov, @woodernrobo, Sophia Brumhard, Philipp Georg @phige21, Anna Hiller, Leif Erik Sander @Sander_Lab, Nils Blüthgen @molsysbio, @RalserLab, @ewyler, @robuelow, @rosasta_g and many others!

[Sawitzki Lab @SawitzkiLab]

Why does age make COVID-19 more dangerous? Our latest study shows molecular shifts with age, revealing how changes in immune signaling drive enhanced inflammation across the immune cell landscape.

https://t.co/hE6ueOco7q

[Sawitzki Lab @SawitzkiLab]

We analyzed patients who had type I IFN autoantibodies. They showed the most extreme phenotype. We even detected similar shift in signaling in young (ISGs) and adult hamsters (S100A genes) infected with COVID-19, suggesting that we discovered a general aging-induced concept.

[DRFZ @DRFZ_Berlin]

Don´t forget to register for the Berlin-wide Immunology & Inflammation Symposium 2024 on Oct 7, at Charité Campus Mitte
Registration and abstract submission deadline is extended until Sep 12!
https://t.co/gQl02MyIGd

DRFZ on behalf of the organization committee

[Anna Aschenbrenner @AschenbrennerAC]

Can single-cell omics enhance clinical studies?

Find out @CellCellPress 👀https://t.co/mAbCvRegQn about the potential of single-cell omics for monitoring in vivo target engagement of immunomodulatory drugs and for patient stratification for precision medicine approaches.

[1/8]

[Leif Erik Sander🇺🇦 @Sander_Lab]

Dexamethasone, a cheap and widely available drug, saved millions of lives during the COVID-19 pandemic.

Our teams @chariteBerlin @berlinnovation and @dzne_en have now decoded the mechanism underlying its life-saving benefit in severe COVID-19.
https://t.co/HS1AgMidFt

[Sawitzki Lab @SawitzkiLab]

New review spearheaded by Anne Noom and Georg Duda on the importance of cellular metabolism in myofibroblast contraction is out now! ⬇️

https://t.co/SjctrQ3rLa

[Sawitzki Lab @SawitzkiLab]

We’re excuted to have you join our team, @Lucas_Arendholz!

[Sawitzki Lab @SawitzkiLab]

📢 Open PhD Position in Sawitzki Lab📢

We are looking for a PhD candidate to study severe immunopathologies using both wet lab and bioinformatics techniques.

Apply by April 3rd 2024! 👇 #PhDposition

https://t.co/yZw31dfyLI

[Long COVID Deutschland (LCD) @LongDeutschland]

Biomarker, diagnostic studies and clinical trials

The #NKSG is conducting in-depth analysis of potential biomarkers and diagnostics for both #LongCovid and #MECFS.
In addition, 5 treatment trials are expected to conclude by the end of 2024. More trials are currently in planning.

[Long COVID Deutschland (LCD) @LongDeutschland]

NKSG website now available in English

Details on the National Clinical Studies Group (#NKSG) for #MECFS & #LongCovid are now available in English: https://t.co/3IOB3LbkQ8
@BMBF_Bund has been funding the group with €10m since late 2022, with another €8m approved for 2025-26.

[Sawitzki Lab @SawitzkiLab]

📢We are looking for a highly motivated PhD student to join our lab in Berlin within an EU doctoral network!

Topic: Cross-tissue organoid immune cell integration and function.

Deadline: November 30th, 2023.

More info: https://t.co/1JXdNuFMIV.

#PhDPosition #MSCA #Immunology